The large nonprofit health system, based in Philadelphia, is suing multiple companies, saying they colluded to raise the price of insulin, which in turn forced the health system to spend more on ...
Congress can pass phamaracy benefit manager reform and deliver transparency, accountability and fairness that New Yorkers ...
On a cold winter morning, a Martella’s Pharmacy driver made a usual medication delivery to a resident of the Valley Pike ...
Oregon's Attorney General sues insulin manufacturers and PBMs for $900 million, alleging price inflation and collusion, ...
The Philadelphia region’s largest health system has sued several drugmakers and pharmacy benefit managers, alleging ...
Philadelphia-based Jefferson Health and Thomas Jefferson University filed a federal lawsuit Dec. 30 alleging that three insulin manufacturers and the nation’s largest pharmacy benefit managers ...
The Oregon Department of Justice on Wednesday sued three of the nation’s largest insulin makers, accusing them of working with pharmacy benefit managers to drive up the price of a drug that diabetics ...
The lawsuit alleges three manufacturers coordinated with three pharmacy benefit managers in a scheme to inflate insulin ...
Thomas Jefferson University Hospital filed a lawsuit against insulin manufacturers and major pharmacy benefit managers in the ...
Attorney General Todd Rokita said the lawsuit, filed last Wednesday in the Lake County Superior Court, is part of his ...
HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...
S&P 500 healthcare recap: top gainers/losers plus key stories on Medicare refill costs, China GLP-1 price wars, and Molina’s Burry boost—read now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results